HVTN Spokespeople

Larry Corey, M.D.

Larry Corey, M.D., HIV Vaccine Trials Network
Larry Corey, M.D., Principal Investigator for the world's largest publicly funded collaboration facilitating the development of vaccines to prevent HIV/AIDS.

Lawrence Corey is past president of the Fred Hutchinson Cancer Research Center and a member of its Vaccine and Infectious Disease, Public Health Sciences and Clinical Research divisions. He is a professor of Medicine and Laboratory Medicine at the University of Washington, was head of the Virology Division at the University of Washington from 1978 to 2010, and led the AIDS Clinical Trials Group (ACTG) from 1987 to 1992. He has been Principal Investigator of the HVTN since its inception in 1999.

An internationally renowned expert in virology, viral immunology and vaccine development, Corey’s research has transformed the way we manage patients globally. With Nobel Laureate Dr. Gertrude Elion, he was the first to demonstrate that an antiviral compound, acyclovir, specific for a viral enzyme could be safely and effectively administered to control a chronic viral infection. These studies provided the foundation for the subsequent development of antiviral therapy for HIV and hepatitis viruses. Under his leadership at the ACTG, AZT was shown to reduce maternal fetal transmission; providing the impetus for the introduction of antiretrovirals to avert pediatric HIV infections internationally. He pioneered the use of viral load as predictors of clinical benefit and his studies demonstrating the early administration of combination antiretroviral therapy provided the strategy to reduce HIV morbidity and mortality globally. Corey’s work in HSV-2 established the framework for understanding the herpes pandemic and its role in HIV acquisition and progression.

Corey received his B.S. and M.D. from the University of Michigan and his infectious diseases training at the University of Washington. He is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences, was the recipient of the Parran Award for his work in HSV-2, the American Society of Microbiology Cubist Award for his work on antivirals, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the last 20 years and is the author, coauthor or editor of over 1000 scientific publications.

Stephaun E. Wallace, PhD

Stephaun Wallace, PhD, is the HVTN’s Director of External Relations.

Stephaun Wallace is the Director of External Relations of the HVTN. His focus is on building long-term relationships with key stakeholders by leading the Network’s external relations strategies and efforts, globally. Those strategies create opportunities for consultation with key stakeholders and communities to inform the design and implementation of Network studies. Those consultations optimize the inclusion and participation of populations and communities who bear the greatest burden of HIV.

Dr. Wallace is a Staff Scientist in the Vaccine and Infectious Disease Division at Fred Hutch, and a Clinical Assistant Professor in the Department of Global Health at the University of Washington. An internationally recognized public health/social justice leader, public speaker, and thought leader, Dr. Wallace has more than 20 years of sexual/public health experience and more than 25 years of grassroots social justice/community mobilization experience, with diverse populations, including MSM and transgender populations. Dr. Wallace views public health work through a social justice lens to understand how population-level health is impacted by structural and social factors like stigma, racism, sexism, historical trauma, and education and income inequalities.

Michele Andrasik, PhD

Michele Andrasik, PhD, is the HVTN’s Director of Social and Behavioral Sciences and Community Engagement

Michele Andrasik is a clinical health psychologist. As the Director of Social and Behavioral Sciences and Community Engagement for the HVTN, Dr. Andrasik has led a robust Social and Behavioral Sciences research agenda for almost a decade. She has extensive experience working with communities and community organizations, both as a researcher and as a service provider. Prior to her doctoral training, Dr. Andrasik served as the Director of AIDS Services for a community-based HIV/AIDS service organization with offices in the New York City boroughs of Brooklyn and Manhattan. 

Dr. Andrasik’s research focus is on HIV prevention and social and structural factors implicated in health inequities. She brings her extensive expertise utilizing Community-Based Participatory Research (CBPR) and Qualitative Research Methods. Dr. Andrasik is also a Senior Staff Scientist in the Fred Hutchinson Vaccine and Infectious Disease Division and an Affiliate Assistant Professor in the Departments of Global Health and Environmental and Occupational Health Sciences at the University of Washington.